May A Beydoun1, Nicole Noren Hooten1, Ana I Maldonado2, Hind A Beydoun3, Jordan Weiss4, Michele K Evans1, Alan B Zonderman1. 1. Laboratory of Epidemiology and Population Sciences, National Institute on Aging/NIH/Intramural Research Program, Baltimore, MD, USA. 2. Department of Psychology, University of Maryland, Baltimore County, Catonsville, MD, USA. 3. Department of Research Programs, Fort Belvoir Community Hospital, Fort Belvoir, VA, USA. 4. Department of Demography, University of California, Berkeley, Berkeley, CA, USA.
Abstract
BACKGROUND: Plasma neurofilament light chain (NfL) is a novel biomarker for age-related neurodegenerative disease. We tested whether NfL may be linked to cardiometabolic risk factors, including BMI, the allostatic load (AL) total score (ALtotal), and related AL continuous components (ALcomp). We also tested whether these relations may differ by sex or by race. METHODS: We used data from the HANDLS (Healthy Aging in Neighborhoods of Diversity across the Life Span) study [n = 608, age at visit 1 (v1: 2004-2009): 30-66 y, 42% male, 58% African American] to investigate associations of initial cardiometabolic risk factors and time-dependent plasma NfL concentrations over 3 visits (2004-2017; mean ± SD follow-up time: 7.72 ± 1.28 y), with outcomes being NfLv1 and annualized change in NfL (δNfL). We used mixed-effects linear regression and structural equations modeling (SM). RESULTS: BMI was associated with lower initial (γ01 = -0.014 ± 0.002, P < 0.001) but faster increase in plasma NfL over time (γ11 = +0.0012 ± 0.0003, P < 0.001), a pattern replicated for ALtotal. High-sensitivity C-reactive protein (hsCRP), serum total cholesterol, and resting heart rate at v1 were linked with faster plasma NfL increase over time, overall, while being uncorrelated with NfLv1 (e.g., hsCRP × Time, full model: γ11 = +0.004 ± 0.002, P = 0.015). In SM analyses, BMI's association with δNfL was significantly mediated through ALtotal among women [total effect (TE) = +0.0014 ± 0.00038, P < 0.001; indirect effect = +0.00042 ± 0.00019, P = 0.025; mediation proportion = 30%], with only a direct effect (DE) detected among African American adults (TE = +0.0011 ± 0.0004, P = 0.015; DE = +0.0010 ± 0.00048, P = 0.034). The positive associations between ALtotal/BMI and δNfL were mediated through increased glycated hemoglobin (HbA1c) concentrations, overall. CONCLUSIONS: Cardiometabolic risk factors, particularly elevated HbA1c, should be screened and targeted for neurodegenerative disease, pending comparable longitudinal studies. Other studies examining the clinical utility of plasma NfL as a neurodegeneration marker should account for confounding effects of BMI and AL. Published by Oxford University Press on behalf of the American Society for Nutrition 2021.
BACKGROUND: Plasma neurofilament light chain (NfL) is a novel biomarker for age-related neurodegenerative disease. We tested whether NfL may be linked to cardiometabolic risk factors, including BMI, the allostatic load (AL) total score (ALtotal), and related AL continuous components (ALcomp). We also tested whether these relations may differ by sex or by race. METHODS: We used data from the HANDLS (Healthy Aging in Neighborhoods of Diversity across the Life Span) study [n = 608, age at visit 1 (v1: 2004-2009): 30-66 y, 42% male, 58% African American] to investigate associations of initial cardiometabolic risk factors and time-dependent plasma NfL concentrations over 3 visits (2004-2017; mean ± SD follow-up time: 7.72 ± 1.28 y), with outcomes being NfLv1 and annualized change in NfL (δNfL). We used mixed-effects linear regression and structural equations modeling (SM). RESULTS: BMI was associated with lower initial (γ01 = -0.014 ± 0.002, P < 0.001) but faster increase in plasma NfL over time (γ11 = +0.0012 ± 0.0003, P < 0.001), a pattern replicated for ALtotal. High-sensitivity C-reactive protein (hsCRP), serum total cholesterol, and resting heart rate at v1 were linked with faster plasma NfL increase over time, overall, while being uncorrelated with NfLv1 (e.g., hsCRP × Time, full model: γ11 = +0.004 ± 0.002, P = 0.015). In SM analyses, BMI's association with δNfL was significantly mediated through ALtotal among women [total effect (TE) = +0.0014 ± 0.00038, P < 0.001; indirect effect = +0.00042 ± 0.00019, P = 0.025; mediation proportion = 30%], with only a direct effect (DE) detected among African American adults (TE = +0.0011 ± 0.0004, P = 0.015; DE = +0.0010 ± 0.00048, P = 0.034). The positive associations between ALtotal/BMI and δNfL were mediated through increased glycated hemoglobin (HbA1c) concentrations, overall. CONCLUSIONS: Cardiometabolic risk factors, particularly elevated HbA1c, should be screened and targeted for neurodegenerative disease, pending comparable longitudinal studies. Other studies examining the clinical utility of plasma NfL as a neurodegeneration marker should account for confounding effects of BMI and AL. Published by Oxford University Press on behalf of the American Society for Nutrition 2021.
Entities:
Keywords:
allostatic load; body mass index; cognition; neurofilament light; race; urban adults
Authors: Youfa Wang; May A Beydoun; Jungwon Min; Hong Xue; Leonard A Kaminsky; Lawrence J Cheskin Journal: Int J Epidemiol Date: 2020-06-01 Impact factor: 7.196
Authors: Rebecca F Gottesman; Marilyn S Albert; Alvaro Alonso; Laura H Coker; Josef Coresh; Sonia M Davis; Jennifer A Deal; Guy M McKhann; Thomas H Mosley; A Richey Sharrett; Andrea L C Schneider; B Gwen Windham; Lisa M Wruck; David S Knopman Journal: JAMA Neurol Date: 2017-10-01 Impact factor: 18.302
Authors: Oliver Preische; Stephanie A Schultz; Anja Apel; Jens Kuhle; Stephan A Kaeser; Christian Barro; Susanne Gräber; Elke Kuder-Buletta; Christian LaFougere; Christoph Laske; Jonathan Vöglein; Johannes Levin; Colin L Masters; Ralph Martins; Peter R Schofield; Martin N Rossor; Neill R Graff-Radford; Stephen Salloway; Bernardino Ghetti; John M Ringman; James M Noble; Jasmeer Chhatwal; Alison M Goate; Tammie L S Benzinger; John C Morris; Randall J Bateman; Guoqiao Wang; Anne M Fagan; Eric M McDade; Brian A Gordon; Mathias Jucker Journal: Nat Med Date: 2019-01-21 Impact factor: 53.440
Authors: M A Beydoun; H A Beydoun; N Mode; G A Dore; J A Canas; S M Eid; A B Zonderman Journal: BMC Public Health Date: 2016-10-22 Impact factor: 3.295
Authors: Frederic Sampedro; Nicole Stantonyonge; Saül Martínez-Horta; Daniel Alcolea; Alberto Lleó; Laia Muñoz; Rocío Pérez-González; Juan Marín-Lahoz; Beatriz Gómez-Ansón; Ana Chico Journal: BMJ Open Diabetes Res Care Date: 2020-07
Authors: Philip S J Weston; Teresa Poole; Antoinette O'Connor; Amanda Heslegrave; Natalie S Ryan; Yuying Liang; Ronald Druyeh; Simon Mead; Kaj Blennow; Jonathan M Schott; Chris Frost; Henrik Zetterberg; Nick C Fox Journal: Alzheimers Res Ther Date: 2019-02-20 Impact factor: 8.823
Authors: Kathryn C Fitzgerald; Elias S Sotirchos; Matthew D Smith; Hannah-Noelle Lord; Anna DuVal; Ellen M Mowry; Peter A Calabresi Journal: Ann Neurol Date: 2022-07-13 Impact factor: 11.274
Authors: May A Beydoun; Nicole Noren Hooten; Michele K Evans; Alan B Zonderman; Jordan Weiss; Hind A Beydoun; Sharmin Hossain Journal: BMC Med Date: 2022-06-13 Impact factor: 11.150
Authors: May A Beydoun; Hind A Beydoun; Nicole Noren Hooten; Ana I Maldonado; Jordan Weiss; Michele K Evans; Alan B Zonderman Journal: Aging (Albany NY) Date: 2022-07-01 Impact factor: 5.955
Authors: Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei Journal: Int J Mol Sci Date: 2022-03-21 Impact factor: 5.923